Showing 65,641 - 65,660 results of 66,534 for search 'LZRW~', query time: 1.40s Refine Results
  1. 65641

    High-Resolution Genomic Profiling of Liver Cancer Links Etiology With Mutation and Epigenetic SignaturesSummary by Shira Perez, Anat Lavi-Itzkovitz, Moriah Gidoni, Tom Domovitz, Roba Dabour, Ishant Khurana, Ateret Davidovich, Ana Tobar, Alejandro Livoff, Evgeny Solomonov, Yaakov Maman, Assam El-Osta, Yishan Tsai, Ming-Lung Yu, Salomon M. Stemmer, Izhak Haviv, Gur Yaari, Meital Gal-Tanamy

    Published 2023-01-01
    “…Results: Regional variation in mutation rate analysis showed significant etiology-dependent regional mutation rates in 12 genes: LRP2, KRT84, TMEM132B, DOCK2, DMD, INADL, JAK2, DNAH6, MTMR9, ATM, SLX4, and ARSD. …”
    Get full text
    Article
  2. 65642

    Towards closing the security gap of Tweak-aNd-Tweak (TNT) by Guo, Chun, Guo, Jian, List, Eik, Song, Ling

    Published 2021
    “…In this work, we show that a variant of Mennink’s distinguisher on CLRW2 with O(n23n/4) data and O(23n/2) time from TCC’18 also applies to TNT. …”
    Get full text
    Conference Paper
  3. 65643
  4. 65644

    Genetic and phenotypic similarity across major psychiatric disorders: a systematic review and quantitative assessment by Vincent-Raphael Bourque, Cécile Poulain, Catherine Proulx, Clara A. Moreau, Ridha Joober, Baudouin Forgeot d’Arc, Guillaume Huguet, Sébastien Jacquemont

    Published 2024-03-01
    “…Our findings highlight that genetic and brain factors may underlie a large proportion, but not all of the diagnostic overlaps observed in the clinic.…”
    Get full text
    Article
  5. 65645
  6. 65646

    Detection of gene mutations and gene–gene fusions in circulating cell‐free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis by Vikrant Palande, Tali Siegal, Rajesh Detroja, Alessandro Gorohovski, Rainer Glass, Charlotte Flueh, Andrew A. Kanner, Yoseph Laviv, Sagi Har‐Nof, Adva Levy‐Barda, Marcela Viviana Karpuj, Marina Kurtz, Shira Perez, Dorith Raviv Shay, Milana Frenkel‐Morgenstern

    Published 2022-05-01
    “…We identified unique mutations in the cfDNA and tumour DNA of each GBM patient, including some of the most frequently mutated genes in GBM according to the COSMIC database (TP53, 18.75%; EGFR, 37.5%; NF1, 12.5%; LRP1B, 25%; IRS4, 25%). Using our gene–gene fusion database, ChiTaRS 5.0, we identified gene–gene fusions in cfDNA and tumour DNA, such as KDR–PDGFRA and NCDN–PDGFRA, which correspond to previously reported alterations of PDGFRA in GBM (44% of all samples). …”
    Get full text
    Article
  7. 65647
  8. 65648
  9. 65649
  10. 65650

    Rapid SARS-CoV-2 Detection Using the Lucira™ Check It COVID-19 Test Kit by Maya Zahavi, Hanan Rohana, Maya Azrad, Bracha Shinberg, Avi Peretz

    Published 2022-08-01
    “…The need for the early identification of SARS-CoV-2 has let to a quest for reliable tests that meet the standards of polymerase chain reaction (PCR) tests, on the one hand, and are low-cost, easy-to-use, and fast, on the other hand. …”
    Get full text
    Article
  11. 65651
  12. 65652
  13. 65653
  14. 65654
  15. 65655

    FAK-Mediated Signaling Controls Amyloid Beta Overload, Learning and Memory Deficits in a Mouse Model of Alzheimer’s Disease by Bisan Saleh, Kolluru D. Srikanth, Tal Sneh, Lambert Yue, Steven Pelech, Evan Elliott, Hava Gil-Henn

    Published 2022-08-01
    “…The non-receptor focal adhesion kinase (FAK) is highly expressed in the central nervous system during development, where it regulates neurite outgrowth and axon guidance, but its role in the adult healthy and diseased brain, specifically in Alzheimer’s disease (AD), is largely unknown. Using the 3xTg-AD mouse model, which carries three mutations associated with familial Alzheimer’s disease (APP KM670/671NL Swedish, PSEN1 M146V, MAPT P301L) and develops age-related progressive neuropathology including amyloid plaques and Tau tangles, we describe here, for the first time, the in vivo role of FAK in AD pathology. …”
    Get full text
    Article
  16. 65656
  17. 65657
  18. 65658

    The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis by Hayelom Berhe, Mahesh Kumar Cinthakunta Sridhar, Mulate Zerihun, Nir Qvit

    Published 2024-02-01
    “…Peptide-based drugs are attractive due to their high selectiveness, effectiveness, low toxicity, and ease of production. This paper reviews the potential use of peptides in the treatment of Chagas disease and leishmaniasis. …”
    Get full text
    Article
  19. 65659
  20. 65660